Francisco X Flores, Patrick D Brophy, Jordan M Symons, James D Fortenberry, Annabelle N Chua, Steven R Alexander, John D Mahan, Timothy E Bunchman, Douglas Blowey, Michael J G Somers, Michelle Baum, Richard Hackbarth, Deepa Chand, Kevin McBryde, Mark Benfield, Stuart L Goldstein
Pediatric stem cell transplant (SCT) recipients commonly develop acute renal failure (ARF). We report the demographic and survival data of pediatric SCT patients enrolled in the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry. Since 1 January 2001, 51/370 (13.8%) patients entered in the ppCRRT Registry had received a SCT. Median age was 13.63 (0.53-23.52) years. The primary reasons for the initiation of continuous renal replacement therapy (CRRT) were treatment of fluid overload (FO) and electrolyte imbalance (49%), FO only (39%), electrolyte imbalance only (8%) and other reasons (4%)...
April 2008: Pediatric Nephrology